NO983719L - Neovaskularisasjonsinhibitor - Google Patents

Neovaskularisasjonsinhibitor

Info

Publication number
NO983719L
NO983719L NO983719A NO983719A NO983719L NO 983719 L NO983719 L NO 983719L NO 983719 A NO983719 A NO 983719A NO 983719 A NO983719 A NO 983719A NO 983719 L NO983719 L NO 983719L
Authority
NO
Norway
Prior art keywords
neovaskularisasjonsinhibitor
Prior art date
Application number
NO983719A
Other languages
English (en)
Norwegian (no)
Other versions
NO983719D0 (no
Inventor
Masayuki Isaji
Hiroshi Miyata
Yukiyoshi Ajisawa
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO983719D0 publication Critical patent/NO983719D0/no
Publication of NO983719L publication Critical patent/NO983719L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO983719A 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor NO983719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6509496 1996-02-15
PCT/JP1997/000354 WO1997029744A1 (fr) 1996-02-15 1997-02-12 Inhibiteur de la neoformation de vaisseaux sanguins

Publications (2)

Publication Number Publication Date
NO983719D0 NO983719D0 (no) 1998-08-13
NO983719L true NO983719L (no) 1998-10-14

Family

ID=13277001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983719A NO983719L (no) 1996-02-15 1998-08-13 Neovaskularisasjonsinhibitor

Country Status (11)

Country Link
US (1) US6407139B1 (fr)
EP (1) EP0894496A4 (fr)
KR (1) KR19990082523A (fr)
CN (1) CN1211182A (fr)
BR (1) BR9707514A (fr)
CA (1) CA2246418A1 (fr)
CZ (1) CZ258598A3 (fr)
EA (1) EA199800721A1 (fr)
NO (1) NO983719L (fr)
NZ (1) NZ331339A (fr)
WO (1) WO1997029744A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0950409B1 (fr) * 1996-09-28 2003-04-02 Kissei Pharmaceutical Co. Ltd. Inhibiteur de turbidite sous-epitheliale
WO1998016214A1 (fr) * 1996-10-14 1998-04-23 Kissei Pharmaceutical Co., Ltd. Inhibiteur de la cataracte secondaire
CN1252718A (zh) * 1997-04-18 2000-05-10 橘生药品工业株式会社 预防或治疗与视网膜色素上皮细胞过度增殖相关的疾病的药剂
HK1047274A1 (zh) 1999-07-01 2003-02-14 大正制药株式会社 氨基苯甲酸衍生物
CA2385972A1 (fr) * 1999-10-01 2001-04-12 Haruhisa Ogita Nouveaux derives de diarylamide et utilisation de ces composes comme medicaments
US7531575B2 (en) * 2002-10-31 2009-05-12 Eberhard-Karls-Universität Tübingin Method of modulating cellular activity and agents useful for same
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
US20080009519A1 (en) * 2004-11-17 2008-01-10 Lawrence Steinman Method of modulating t cell functioning
US20100041756A1 (en) * 2004-11-17 2010-02-18 Michael Lionel Selley method of modulating b cell functioning
BRPI0610349A2 (pt) * 2005-05-16 2010-06-15 Angiogen Pharmaceuticals Pty L processos e composições para o tratamento de dor
MX352516B (es) 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
JP2008247789A (ja) * 2007-03-30 2008-10-16 Kissei Pharmaceut Co Ltd クローン病に伴う腸管狭窄の進展抑制用医薬組成物
US20090143388A1 (en) * 2007-08-29 2009-06-04 Mohanakumar Kochupurackal Para Treatment of brain disorders
CA2709937C (fr) 2007-12-21 2016-03-22 Fibrotech Therapeutics Pty Ltd Analogues halogenes d'agents antifibrotiques
JP2011006406A (ja) * 2009-05-29 2011-01-13 Santen Pharmaceut Co Ltd トラニラストを含有する網膜疾患の予防または治療剤
US9592213B2 (en) 2009-06-17 2017-03-14 National University Corporation Kumamoto University Prophylactic and/or therapeutic agent for dysmenorrhea
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
NZ609144A (en) * 2010-11-24 2014-08-29 Occurx Pty Ltd Methods of treating eye diseases associated with inflammation and vascular proliferation
CN102657647A (zh) * 2012-04-06 2012-09-12 澳门大学 Ic-4在抗血管新生中的应用
JP7185631B2 (ja) 2017-02-03 2022-12-07 サータ セラピューティクス プロプライエタリー リミテッド 抗線維化化合物
EP4161527A4 (fr) * 2020-06-05 2024-06-26 OccuRx Pty Ltd Composés et méthodes pour le traitement de troubles oculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163222A (ja) 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
JP2617407B2 (ja) 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US5512591A (en) 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
AU699821B2 (en) 1994-10-17 1998-12-17 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
DE59606488D1 (de) * 1995-08-31 2001-04-05 Infineon Technologies Ag Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
ATE222759T1 (de) * 1996-02-07 2002-09-15 Lead Chem Co Ltd Tranilast enthaltendes externum und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
NZ331339A (en) 2001-02-23
CA2246418A1 (fr) 1997-08-21
NO983719D0 (no) 1998-08-13
CZ258598A3 (cs) 1998-11-11
EP0894496A1 (fr) 1999-02-03
EA199800721A1 (ru) 1999-02-25
US6407139B1 (en) 2002-06-18
WO1997029744A1 (fr) 1997-08-21
EP0894496A4 (fr) 2001-01-03
KR19990082523A (ko) 1999-11-25
CN1211182A (zh) 1999-03-17
BR9707514A (pt) 1999-07-27

Similar Documents

Publication Publication Date Title
BR9703884A (pt) Cicloalcanopiridinas
ATE208395T1 (de) Thiophenopyrimidine
BR9704464A (pt) Evisceradora
ATE262512T1 (de) Arylalkanoylpyridazine
ATE208773T1 (de) Chinoxalindione
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DE59609702D1 (de) Pulversprüheinrichtung
BR9703563A (pt) Hidromancal
BR9703835A (pt) Hidromancal
BR9707467A (pt) 1-Pirazol-3-iletil-4-indol-3-ilpiperdinas
DE59706319D1 (de) Carbamoylcarbonsäureamidoxime
BR9708716A (pt) 3-cianoaril-pirazóis
DE59610630D1 (de) Paradontalsonde
ATE267568T1 (de) Epithese
BR9600112A (pt) Conaço
BR9603976A (pt) Stop-entope
BR7602320U (pt) Supedânea
BR7603088U (pt) Kitgeométrico
BR7603126U (pt) Bate - estacas
BR7603147U (pt) Simborgueup
BR7603380U (pt) Abratporta
BR7603492U (pt) Protemilk
BR7601720U (pt) Paraglayder
BR9600914A (pt) Lipodecantador
BR9600920A (pt) Otimizador-turbinado-nb

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application